Evidence map›Paper›PMID 38703997›Full record

ArticleThe Journal of biological chemistry2024

Tyrosine-modifying glycosylation by Yersinia effectors.

Silvia Schneider, Christophe Wirth, Thomas Jank, Carola Hunte, Klaus Aktories

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Silvia SchneiderFaculty of Medicine, Institute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany.
Christophe WirthFaculty of Medicine, Institute for Biochemistry and Molecular Biology, ZBMZ, University of Freiburg, Freiburg, Germany. Electronic address: christophe.wirth@biochemie.uni-freiburg.de.
Thomas JankFaculty of Medicine, Institute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany.
Carola HunteFaculty of Medicine, Institute for Biochemistry and Molecular Biology, ZBMZ, University of Freiburg, Freiburg, Germany; Centre for Biological Signalling Studies (BIOSS), University of Freiburg, Freiburg, Germany; CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.
Klaus AktoriesFaculty of Medicine, Institute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany; Centre for Biological Signalling Studies (BIOSS), University of Freiburg, Freiburg, Germany. Electronic address: klaus.aktories@pharmakol.uni-freiburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mono-O-glycosylation of target proteins by bacterial toxins or effector proteins is a well-known mechanism by which bacteria interfere with essential functions of host cells. The respective glycosyltransferases are important virulence factors such as the Clostridioides difficile toxins A and B. Here, we describe two glycosyltransferases of Yersinia species that have a high sequence identity: YeGT from the zoonotic pathogen Yersinia enterocolitica and YkGT from the murine pathogen Yersinia kristensenii. We show that both modify Rho family proteins by attachment of GlcNAc at tyrosine residues (Tyr-34 in RhoA). Notably, the enzymes differed in their target protein specificity. While YeGT modified RhoA, B, and C, YkGT possessed a broader substrate spectrum and glycosylated not only Rho but also Rac and Cdc42 subfamily proteins. Mutagenesis studies indicated that residue 177 is important for this broader target spectrum. We determined the crystal structure of YeGT shortened by 16 residues N terminally (sYeGT) in the ligand-free state and bound to UDP, the product of substrate hydrolysis. The structure assigns sYeGT to the GT-A family. It shares high structural similarity to glycosyltransferase domains from toxins. We also demonstrated that the 16 most N-terminal residues of YeGT and YkGT are important for the mediated translocation into the host cell using the pore-forming protective antigen of anthrax toxin. Mediated introduction into HeLa cells or ectopic expression of YeGT and YkGT caused morphological changes and redistribution of the actin cytoskeleton. The data suggest that YeGT and YkGT are likely bacterial effectors belonging to the family of tyrosine glycosylating bacterial glycosyltransferases.

Indexed as

Bacterial ProteinsTyrosineYersiniaAnimalsCrystallography, X-RayGlycosylationGlycosyltransferasesHeLa CellsHumansMicerhoA GTP-Binding ProteinYersinia enterocoliticaYersinia InfectionsBacterial ProteinsGlycosyltransferasesrhoA GTP-Binding ProteinRHOA protein, humanTyrosineClostridioides difficileglycosyltransferasePhotorhabdus asymbiotica toxinRho GTPasestoxintyrosine glycosylationYersinia enterocoliticaYersinia kristenseniiYersinia ruckeri

Identifiers

PMID38703997
PMCPMC11152714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.